BIOLOGICAL · Unmapped registry intervention
AVX901
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901
NCT01526473
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HER2+ Cancerunresolved
Interventions
AVX901BIOLOGICAL
Sponsors & collaborators
H. Kim Lyerlylead sponsor
Susan G. Komen Breast Cancer Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01526473 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.